These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16325127)

  • 21. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
    Damaraju D; Damaraju VL; Brun M; Mowles D; Kuzma M; Berendt RC; Sawyer MB; Cass CE
    Biochem Pharmacol; 2008 May; 75(10):1901-11. PubMed ID: 18371936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
    Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
    Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant pleural mesothelioma: a new standard of care.
    Stahel RA
    Lung Cancer; 2006 Dec; 54 Suppl 2():S9-S14. PubMed ID: 17059852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005 A single institution experience.
    Metintas M; Ak G; Erginel S; Alatas F; Yildirim H; Kurt E; Metintas S
    Lung Cancer; 2007 Mar; 55(3):379-87. PubMed ID: 17174436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
    Obasaju CK; Ye Z; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Monberg MJ; Jänne PA;
    Lung Cancer; 2007 Feb; 55(2):187-94. PubMed ID: 17092602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epothilones: how pharmacology relates to clinical utility.
    Michaud LB
    Ann Pharmacother; 2009 Jul; 43(7):1294-309. PubMed ID: 19584389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant mesothelioma of the pleura: place of surgery].
    Giudicelli R; Regnard JF; Astoul P; Ruffie P
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S106-10S109. PubMed ID: 17127980
    [No Abstract]   [Full Text] [Related]  

  • 29. New therapeutic strategies in acute lymphoblastic leukemia.
    Jeha S
    Semin Hematol; 2009 Jan; 46(1):76-88. PubMed ID: 19100370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraperitoneal chemotherapy in ovarian cancer: an update.
    Runowicz CD
    Cancer J; 2008; 14(1):7-9. PubMed ID: 18303475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the adjuvant treatment of colorectal cancer.
    Nordman IC; Iyer S; Joshua AM; Clarke SJ
    ANZ J Surg; 2006 May; 76(5):373-80. PubMed ID: 16768699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodality strategies in malignant pleural mesothelioma.
    Weder W; Opitz I; Stahel R
    Semin Thorac Cardiovasc Surg; 2009; 21(2):172-6. PubMed ID: 19822290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant pleural mesothelioma: current concepts in treatment.
    Tsiouris A; Walesby RK
    Nat Clin Pract Oncol; 2007 Jun; 4(6):344-52. PubMed ID: 17534390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma.
    McCoy MJ; Nowak AK; Lake RA
    Tissue Antigens; 2009 Jul; 74(1):1-10. PubMed ID: 19422663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant mesothelioma 2008.
    Zervos MD; Bizekis C; Pass HI
    Curr Opin Pulm Med; 2008 Jul; 14(4):303-9. PubMed ID: 18520263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy for recurrent and metastatic cervical cancer.
    Tao X; Hu W; Ramirez PT; Kavanagh JJ
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed.
    Palumbo C; Battisti S; Carbone D; Albonici L; Alimandi M; Bei R; Modesti A
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):893-901. PubMed ID: 17922127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individualizing mesothelioma treatment: small steps into a brighter future.
    Garland L; Flores R; Tsao A
    Clin Lung Cancer; 2010 Nov; 11(6):371-3. PubMed ID: 21062727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.